The Newsroom of Immunophotonics, Inc.

Public Relations
Immunophotonics, Inc.
+1 314-501-1919

Immunophotonics, Inc.
4340 Duncan Avenue, Suite 212
Saint Louis, Missouri, 63110
United States
+1 314-501-1919
Visit Website

Immunophotonics, Inc. is a privately owned clinical-stage biotech company pioneering the field of Interventional Immuno-Oncology™. IP-001, the first asset from the company’s intellectual property platform, has the potential to overcome the local defenses of the tumor microenvironment to enable a tumor-specific anticancer immune response in multiple solid tumor indications. The company is in phase 2 development and is based in St. Louis, Missouri, USA with subsidiaries in Bern, Switzerland and Tianjin, China.